Molecular evidence of synaptic pathology in the CA1 region in schizophrenia

npj Schizophrenia

Volumn 2, Issue , 2016, Pages

  Matosin, Natalie ^a,b,c   Fernandez Enright, Francesca ^b,d   Lum, Jeremy S ^b   Engel, Martin ^b   Andrews, Jessica L ^b   Gassen, Nils C ^a   Wagner, Klaus V ^a   Schmidt, Mathias V ^a   Newell, Kelly A ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR 1; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN HOMER 1; PROTEIN HOMER 1A; PROTEIN HOMER 1B; PROTEIN HOMER 1C; SYNAPTOPHYSIN;

ARTICLE; AUTOPSY; BRAIN; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOBLOTTING; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA;

EID: 84996734038     PISSN: None     EISSN: 2334265X     Source Type: Journal    
DOI: 10.1038/npjschz.2016.22     Document Type: Article

References (75)

1. Tamminga, C. A., Stan, A. D., Wagner, A. D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 167, 1178-1193 (2010).
2. Ranganath, C., Minzenberg, M. J., Ragland, J. D. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol. Psychiatry 64, 18-25 (2008).
3. Carr, M. F., Frank, L. M. A single microcircuit with multiple functions: state dependent information processing in the hippocampus. Curr. Opin. Neurobiol. 22, 704-708 (2012).
4. Hall, J., Trent, S., Thomas, K. L., O'Donovan, M. C., Owen, M. J. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol. Psychiatry 77, 52-58 (2015).
5. Kim, E., Sheng, M. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5, 771-781 (2004).
6. Chen, X. et al. PSD-95 Is required to sustain the molecular organization of the postsynaptic density. J. Neurosci. 31, 6329-6338 (2011).
7. Ehrlich, I., Klein, M., Rumpel, S., Malinow, R. PSD-95 is required for activity-driven synapse stabilization. Proc. Natl Acad. Sci. USA 104, 4176-4181 (2007).
8. Ohnuma, T. et al. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. NeuroReport 11, 3133-3137 (2000).
9. Toyooka, K. et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J. Neurochem. 83, 797-806 (2002).
10. Kristiansen, L. V., Beneyto, M., Haroutunian, V., Meador-Woodruff, J. H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 11, 737-747 (2006).
11. Hammond, J. C., McCullumsmith, R. E., Haroutunian, V., Meador-Woodruff, J. H. Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Schizophr. Res. 130, 260-265 (2011).
12. Mueller, H. T., Haroutunian, V., Davis, K. L., Meador-Woodruff, J. H. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Mol. Brain Res. 121, 60-69 (2004).
13. Kajimoto, Y. et al. Synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia. Neuropsychopharmacology 28, 1831-1839 (2003).
14. Clinton, S. M., Meador-Woodruff, J. H. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29, 1353-1362 (2004).
15. Clinton, S. M., Haroutunian, V., Meador-Woodruff, J. H. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J. Neurochem. 98, 1114-1125 (2006).
16. Clinton, S. M., Haroutunian, V., Davis, K. L., Meador-Woodruff, J. H. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 160, 1100-1109 (2003).
17. Funk, A. J., Rumbaugh, G., Harotunian, V., McCullumsmith, R. E., Meador-Woodruff, J. H. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 20, 1019 (2009).
18. Beneyto, M., Meador-Woodruff, J. H. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33, 2175-2186 (2008).
19. Li, W. et al. Synaptic proteins in schizophrenia hippocampus indicate increased neuronal activity in CA3. Am. J. Psychiatry 172, 373-382 (2015).
20. McCullumsmith, R. E., et al. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res. 1127, 108-118 (2007).
21. Toro, C., Deakin, J. F. W. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res. 80, 323-330 (2005).
22. Engmann, O. et al. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 134, 2408-2421 (2011).
23. Matosin, N. et al. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia. Schizophr Res. 166, 212-218 (2015).
24. Hu, J.-H. et al. Preso1 dynamically regulates group I metabotropic glutamate receptors. Nat. Neurosci. 15, 836-844 (2012).
25. Lee, H. W. et al. Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis. J. Neurosci. 28, 14546-14556 (2008).
26. Matosin, N. et al. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation. Acta Neuropathol. 130, 119-129 (2015).
27. Blanpied, T. A., Kerr, J. M., Ehlers, M. D. Structural plasticity with preserved topology in the postsynaptic protein network. Proc. Natl Acad. Sci. USA 105, 12587-12592 (2008).
28. Sturgill, J. F., Steiner, P., Czervionke, B. L., Sabatini, B. L. Distinct Domains within PSD-95 mediate synaptic incorporation, stabilization, and activity-dependent trafficking. J. Neurosci. 29, 12845-12854 (2009).
29. Kitano, J. et al. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins. J. Neurosci. 22, 1280-1289 (2002).
30. Tu, J. C. et al. Coupling of mGluR/Homer and PSD-95 complexes by the shank family of postsynaptic density proteins. Neuron 23, 583-592 (1999).
31. Kitano, J. et al. Tamalin is a scaffold protein that interacts with multiple neuronal proteins in distinct modes of protein-protein association. J. Biol. Chem. 278, 14762-14768 (2003).
32. Gupta, D. S. et al. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57, 123-131 (2005).
33. Volk, D. W., Eggan, S. M., Lewis, D. A. Alterations in metabotropic glutamate receptor 1a and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am. J. Psychiatry 167, 1489-1498 (2010).
34. Narr, K. L. et al. Regional specificity of hippocampal volume reductions in firstepisode schizophrenia. NeuroImage 21, 1563-1575 (2004).
35. Zierhut K. C. et al. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. Brain 2013; 1-11.
36. Kawasaki, Y. et al. Regional cerebral blood-flow in patients with schizophrenia-a preliminary-report. Eur. Arch. Psychiatry Clin. Neurosci. 241, 195-200 (1992).
37. Hu, W., MacDonald, M. L., Elswick, D. E., Sweet, R. A. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann. N Y Acad. Sci. 1338, 38-57 (2014).
38. Szumlinski, K. K., Kalivas, P. W., Worley, P. F. Homer proteins: implications for neuropsychiatric disorders. Curr. Opin. Neurobiol. 16, 251-257 (2006).
39. Zierhut, K. et al. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res. Neuroimaging 183, 187-194 (2010).
40. Talati, P., Rane, S., Skinner, J., Gore, J., Heckers, S. Increased hippocampal blood volume and normal blood flow in schizophrenia. Psychiatry Res. 232, 219-225 (2015).
41. Schobel, S. A. et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch. Gen. Psychiatry 66, 938 (2009).
42. Gur, R. et al. Resting cerebral glucose-metabolism in first-episode and previously treated patients with schizophrenia relates to clinical-features. Arch. Gen. Psychiatry 52, 657-667 (1995).
43. Heckers, S. et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1, 318-323 (1998).
44. Fortin, D. A. et al. Live imaging of endogenous PSD-95 using ENABLED: a conditional strategy to fluorescently label endogenous proteins. J. Neurosci. 34, 16698-16712 (2014).
45. Masliah, E., Terry, R. D., Alford, M., DeTeresa, R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38, 837-844 (1990).
46. Koffie, R. M. et al. Oligomeric amyloid ? associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl Acad. Sci. USA 106, 4012-4017 (2009).
47. Law, A. J., Weickert, C. S., Hyde, T. M., Kleinman, J. E., Harrison, P. J. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am. J. Psychiatry 161, 1848-1855 (2004).
48. MacGillavry, H. D., Song, Y., Raghavachari, S., Blanpied, T. A. Nanoscale scaffolding domains within the postsynaptic density concentrate synaptic AMPA receptors. Neuron 78, 615-622 (2013).
49. Kaja, S. et al. Homer-1a immediate early gene expression correlates with better cognitive performance in aging. Age Dordr. Neth. 35, 1799-1808 (2013).
50. Segal, M., Korkotian, E. Endoplasmic reticulum calcium stores in dendritic spines. Front. Neuroanat. 8, 1-7 (2014).
51. Kammermeier, P. J. Endogenous homer proteins regulate metabotropic glutamate receptor signaling in neurons. J. Neurosci. 28, 8560-8567 (2008).
52. Saito, H., Kimura, M., Inanobe, A., Ohe, T., Kurachi, Y. An N-terminal sequence specific for a novel Homer1 isoform controls trafficking of group I metabotropic glutamate receptor in mammalian cells. Biochem. Biophys. Res. Commun. 296, 523-529 (2002).
53. Lisman, J. E. et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242 (2008).
54. Heckers, S., Heinsen, H., Geiger, B., Beckmann, H. Hippocampal neuron number in schizophrenia: a stereological study. Arch. Gen. Psychiatry 48, 1002 (1991).
55. Konradi, C. et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr. Res. 131, 165-173 (2011).
56. Schmitt, A. et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol. 117, 395-407 (2009).
57. Walker, M. A. et al. Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am. J. Psychiatry 159, 821-828 (2002).
58. Steiner, J. et al. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: a post-mortem study. Schizophr. Res. 2016 Feb 24. pii: S0920-9964(16)30074-3. doi: 10.1016/j. schres.2016.02.018 (Epub ahead of print).
59. Zhang, Z. J., Reynolds, G. P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55, 1-10 (2002).
60. Benes, F. M., Kwok, E. W., Vincent, S. L., Todtenkopf, M. S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry 44, 88-97 (1998).
61. Heckers, S. et al. DIfferential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59, 521-529 (2002).
62. Heckers, S., Konradi, C. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. Schizophr. Res. 167, 4-11 (2015).
63. Mannaioni, G., Marino, M. J., Valenti, O., Traynelis, S. F., Conn, P. J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21, 5925-5934 (2001).
64. Ferraguti, F. et al. Immunolocalization of metabotropic glutamate receptor 1? (mGluR1?) in distinct classes of interneuron in the CA1 region of the rat hippocampus. Hippocampus 14, 193-215 (2004).
65. Blackshaw, S. et al. Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity. Neuroscience 119, 979-990 (2003).
66. Thompson, C. L. et al. Genomic anatomy of the hippocampus. Neuron 60, 1010-1021 (2008).
67. Nithianantharajah, J., Hannan, A. J. Enriched environments, experiencedependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7, 697-709 (2006).
68. Vazdarjanova, A., McNaughton, B. L., Barnes, C. A., Worley, P. F., Guzowski, J. F. Experience-dependent coincident expression of the effector immediate-early genes arc and Homer 1a in hippocampal and neocortical neuronal networks. J. Neurosci. 22, 10067-10071 (2002).
69. Matosin N. Exploring mGluR5 dysregulation in schizophrenia: from gene to protein. Available at: http://ro.uow.edu.au/theses/4439/. 2015. (accessed on 26 November 2015).
70. de Bartolomeis, A., Latte, G., Tomasetti, C., Iasevoli, F. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Mol. Neurobiol. 49, 484-511 (2014).
71. Barr, A. M., Young, C. E., Phillips, A. G., Honer, W. G. Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. Int. J. Neuropsychopharmacol. 9, 457 (2006).
72. McCullumsmith, R. E., Hammond, J. H., Shan, D., Meador-Woodruff, J. H. Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology 39, 65-87 (2014).
73. Feyissa, A. M., Chandran, A., Stockmeier, C. A., Karolewicz, B. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 70-75 (2009).
74. Weickert, C. S. et al. Selection of reference gene expression in a schizophrenia brain cohort. Aust. N Z J. Psychiatry 44, 59-70 (2010).
75. Fernandez-Enright, F., Andrews, J. L., Newell, K. A., Pantelis, C., Huang, X. F. Novel implications of Lingo-1 and its signaling partners in schizophrenia. Transl. Psychiatry 4, e348 (2014).